Panel Discussion

Monday, March 9, 2026

3:30 PM - 4:00 PM EST

Location: Monroe

Moderator(s)

Kristyn Gordon, ANP-BC

Senior Manager Medical Affairs
Getinge
Nicholasville, Kentucky, United States

Disclosure(s): Maquet Getinge: Employee (Ongoing)
Alexander G. Truesdell, MD

Interventional Cardiology
Virginia Heart / Inova Schar Heart and Vascular
McLean, Virginia, United States

Disclosure(s): Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Chiesi: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Getinge: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panel Discussant(s)

Ian C. Gilchrist, Sr., MD, MSCAI

Professor of Interventional Cardiology
Dartmouth Hitchcock Medical Center
Moultonborough, New Hampshire, United States

Disclosure(s): No financial relationships to disclose
David Israeli, MD, MBA

CEO
Magenta Medical Ltd.
New York, New York, United States

Disclosure(s): Magenta Medical Ltd.: Employee (Ongoing), Stock Options [in privately held companies] (Ongoing)
Mariell Jessup, MD

Chief Science and Medical Officer
American Heart Association
Philadelphia, Pennsylvania, United States

Disclosure(s): No financial relationships to disclose
PL

Pierre Luca Lombardi, MD

Disclosure information not submitted.
Nitin Salunke, PhD

CEO
Supira Medical, California, United States

Disclosure(s): Supira Medical: Employee (Ongoing)
Robert W. Yeh, MD, MSc

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing)
Bram Zuckerman, MD

Director Office of CV Devices
U.S. Food and Drug Administration
Silver Spring, Maryland, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Kristyn Gordon, ANP-BC: Maquet Getinge: Employee (Ongoing)

Alexander G. Truesdell, MD: Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Chiesi: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Getinge: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Ian C. Gilchrist, MD, MSCAI, Sr.: No financial relationships to disclose

David Israeli, MD, MBA: Magenta Medical Ltd.: Employee (Ongoing), Stock Options [in privately held companies] (Ongoing)

Mariell Jessup, MD: No financial relationships to disclose

Nitin Salunke, PhD: Supira Medical: Employee (Ongoing)

Robert W. Yeh, MD, MSc: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing)

Bram Zuckerman, MD: No financial relationships to disclose